1. Home
  2. NEPH vs FMY Comparison

NEPH vs FMY Comparison

Compare NEPH & FMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEPH
  • FMY
  • Stock Information
  • Founded
  • NEPH 1997
  • FMY 2005
  • Country
  • NEPH United States
  • FMY United States
  • Employees
  • NEPH N/A
  • FMY N/A
  • Industry
  • NEPH Medical/Dental Instruments
  • FMY Finance/Investors Services
  • Sector
  • NEPH Health Care
  • FMY Finance
  • Exchange
  • NEPH Nasdaq
  • FMY Nasdaq
  • Market Cap
  • NEPH 45.3M
  • FMY 50.5M
  • IPO Year
  • NEPH 2004
  • FMY N/A
  • Fundamental
  • Price
  • NEPH $5.71
  • FMY $12.18
  • Analyst Decision
  • NEPH Strong Buy
  • FMY
  • Analyst Count
  • NEPH 2
  • FMY 0
  • Target Price
  • NEPH $5.50
  • FMY N/A
  • AVG Volume (30 Days)
  • NEPH 66.1K
  • FMY 10.1K
  • Earning Date
  • NEPH 11-06-2025
  • FMY 01-01-0001
  • Dividend Yield
  • NEPH N/A
  • FMY 6.98%
  • EPS Growth
  • NEPH N/A
  • FMY N/A
  • EPS
  • NEPH 0.12
  • FMY N/A
  • Revenue
  • NEPH $16,684,000.00
  • FMY N/A
  • Revenue This Year
  • NEPH $24.38
  • FMY N/A
  • Revenue Next Year
  • NEPH $10.16
  • FMY N/A
  • P/E Ratio
  • NEPH $47.49
  • FMY N/A
  • Revenue Growth
  • NEPH 21.16
  • FMY N/A
  • 52 Week Low
  • NEPH $1.36
  • FMY $10.71
  • 52 Week High
  • NEPH $5.94
  • FMY $12.17
  • Technical
  • Relative Strength Index (RSI)
  • NEPH 76.00
  • FMY 44.32
  • Support Level
  • NEPH $4.52
  • FMY $12.11
  • Resistance Level
  • NEPH $4.89
  • FMY $12.31
  • Average True Range (ATR)
  • NEPH 0.34
  • FMY 0.08
  • MACD
  • NEPH 0.12
  • FMY -0.01
  • Stochastic Oscillator
  • NEPH 87.01
  • FMY 33.61

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

About FMY First Trust Motgage Income Fund of Beneficial Interest

First Trust Mortgage Income Fund is a United States based diversified, closed-end management investment company. The fund's primary investment objective is to seek a high level of current income. Its secondary investment objective is to preserve capital. The fund pursues its objectives by investing predominantly in mortgage-backed securities representing part ownership in a pool of either residential or commercial mortgage loans that, in the opinion of the Fund's investment advisor, offer an attractive combination of credit quality, yield and maturity.

Share on Social Networks: